skip to content

Department of Pharmacology

 
Dr Mark  Waterhouse

The department would like to congratulate Dr Mark Waterhouse from Khaled Lab on being selected as one of the six finalists for AstraZeneca’s R&D Postdoctoral Challenge.

AstraZeneca recently held its R&D Postdoctoral Challenge with research positions for two years at one of the Company’s strategic R&D centres in Cambridge, UK, Gaithersburg, US or Gothenburg, Sweden. From more than 120 proposals, six winners were selected by a judging panel of AstraZeneca and external life science leaders, based on scientific merit and potential to create a real impact for patients, society and healthcare systems. Unlike traditional pre-defined industry postdoctoral initiatives, the Challenge which launched in March 2022, encouraged early career scientists to submit their own research proposals to accelerate drug discovery for some of the world’s most complex diseases.

From more than 120 proposals, six winners were selected by a judging panel of AstraZeneca and external life science leaders, based on scientific merit and potential to create a real impact for patients, society and healthcare systems.

Prof. Sir Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: “We launched the R&D Postdoctoral Challenge to promote diversity of thought and stimulate research opportunities across the globe. The final event was successful in bringing together the brightest minds to help them turn their ideas into meaningful benefits for patients and fuel their early career development. I look forward to re-running the programme in future years.”

You can find more information on the links below: